Panic Developments – An Interesting Editorial by Donald F. Klein in the Revista Brasileira de Psiquiatria
Posted on February 4, 2013 by
Revista Brasileira de Psiquiatria 2012;34(Supl1):S01-S04 Panic Developments This editorial permits personal conclusions and questions, hoping to stimulate relevant research. Klein, in 1959, serendipitously found that imipramine blocked the apparently spontaneous panic attack in non-depressed inpatients, later considered agoraphobic.Later it was found that these specific anti-panic drugs blocked lactate challenges, although low potency benzodiazepines and beta-blockers […]
Ben Goldacre: What doctors don't know about the drugs they prescribe | Video on TED.com
Posted on January 19, 2013 by
Ben Goldacre: What doctors don’t know about the drugs they prescribe via Ben Goldacre: What doctors don’t know about the drugs they prescribe | Video on TED.com.
Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri.
Posted on January 16, 2013 by
Biol Pharm Bull. 2006 Sep;29(9):1976-9. Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri. Akihisa T, Tabata K, Banno N, Tokuda H, Nishimura R, Nakamura Y, Kimura Y, Yasukawa K, Suzuki T. Source College of Science and Technology, Nihon University, Tokyo, Japan. akihisa@chem.cst.nihon-u.ac.jp Erratum in Biol Pharm Bull. […]
Selenium and the thyroid: a close-knit connection.
Posted on by
J Clin Endocrinol Metab. 2010 Dec;95(12):5180-8. doi: 10.1210/jc.2010-0191. Epub 2010 Sep 1. Selenium and the thyroid: a close-knit connection. Duntas LH. Source Endocrine Unit, Evgenidion Hospital, University of Athens, 20 Papadiamantopoulou Street 115 28 Athens, Greece. ledunt@otenet.gr Abstract CONTEXT: The recent recognition that the essential trace element selenium is incorporated as selenocysteine in all three […]
Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance.
Posted on by
Arch Neurol. 2012 Feb;69(2):183-90. doi: 10.1001/archneurol.2011.1426. Epub 2011 Oct 10. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance. Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O’Connor PW, […]